WallStreetZenWallStreetZen

NASDAQ: RGC
Regencell Bioscience Holdings Revenue

OverviewEarningsRevenue
DividendOwnership
Regencell Bioscience Holdings revenue was $0.00 for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2024) ending on Jun 30, 2024 was N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, RGC annual revenue was $0.0, with N/A growth year-over-year.

RGC revenue history

Current Revenue
$0.0
Current Earnings
-$4.3M
Current Profit Margin
0%

Be the first to know when RGC announces revenue.

RGC Revenue History By Year

RGC Yearly RevenueRGC RevenueRGC ChangeRGC Revenue Growth
2024-06-30$0.00N/AN/A
2023-06-30$0.00N/AN/A
2022-06-30$0.00N/AN/A
2021-06-30$0.00N/AN/A
2020-06-30$0.00N/AN/A
2019-06-30$0.00N/AN/A

1 of 1

Regencell Bioscience Holdings Revenue FAQ

What was RGC's revenue last quarter?

Regencell Bioscience Holdings (NASDAQ: RGC) reported Q2 2024 revenue of N/A up N/A year over year. In the same quarter last year, Regencell Bioscience Holdings's revenue was N/A.

What was Regencell Bioscience Holdings's revenue in 2024?

Regencell Bioscience Holdings's annual revenue for the twelve months ending Jun 30, 2024 was $0.00, a N/A decrease year over year.

How much does Regencell Bioscience Holdings make in a day?

Based on Regencell Bioscience Holdings annual revenue for the past five years, RGC makes an average of $0.00 per day.

What was Regencell Bioscience Holdings's annual revenue growth in the past year?

As of Q2 2025, Regencell Bioscience Holdings's revenue has grown null year over year. Regencell Bioscience Holdings's revenue in the past year totaled $0.00.

How much does Regencell Bioscience Holdings make in a year?

Regencell Bioscience Holdings's revenue by year for the past five years is:
  • Regencell Bioscience Holdings's revenue for the twelve months ending Jun 30, 2024 was $0.00, a N/A decrease year over year.
  • Regencell Bioscience Holdings's annual revenue for Jun 30, 2023 was $0.00, a N/A decrease from 2022.
  • Regencell Bioscience Holdings's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Regencell Bioscience Holdings's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Regencell Bioscience Holdings's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.